Fourth quarter and full year 2020 results

Sanofi delivered close to double digit Q4 2020 business EPS growth at CER

Fourth quarter and full-year 2020 results were reviewed by management during a live audio webcast with the financial community.
Fourth quarter and full-year 2020 results were followed by a virtual Capital Markets Day (CMD21).

• Presentation
• Press release
• Q4 and FY 2020 income statements, cash flow statements, balance sheet
• Q4 and FY 2020 net sales by GBU, franchise, geographic region and product
• Clinical trials appendices
• Download infographic
• Q4 2020 Memorandum for modelling purposes

Webcast details

• Recorded audio webcast